Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin.
Concurrent administration of sodium thiosulfate (STS) can protect against the nephrotoxic effects of even very-high-dose cisplatin (CDDP) (i.e., 270 mg/m2 given intraperitoneally). The effect of STS on the pharmacology and toxicity of CDDP was investigated in patients receiving at each treatment 90 mg of CDDP/m2 intraperitoneally, with STS given concurrently on alternate cycles by the intravenous route. The patients received a total of 38 courses of therapy, 21 without STS and 17 with STS. STS reduced the total exposure to diethyldithiocarbamate-reactive CDDP for the peritoneal cavity and plasma by 36% and 25%, respectively. When given alone, CDDP caused a statistically significant acute reduction in creatinine clearance levels; this reduction was less evident when STS was given. We conclude that, whereas STS does reduce systemic exposure, the magnitude of this effect was not sufficient to account for the ability of STS to protect against high-dose CDDP.
Goel
R
R
Department of Medicine, University of California, San Diego, La Jolla 92093.
Cleary
S M
SM
Horton
C
C
Kirmani
S
S
Abramson
I
I
Kelly
C
C
Howell
S B
SB
D002945:Cisplatin / Q000493:pharmacokinetics* / Q000633:toxicity; D004050:Ditiocarb / Q000494:pharmacology; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008274:Magnesium / Q000097:blood; D013885:Thiosulfates / Q000493:pharmacokinetics / Q000494:pharmacology*
D013885:Thiosulfates; D004050:Ditiocarb; C017717:sodium thiosulfate; D008274:Magnesium; D002945:Cisplatin